Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Camp4 Therapeutics (CAMP) Invested Capital (2023 - 2026)

Camp4 Therapeutics' Invested Capital history spans 3 years, with the latest figure at $47.7 million for Q4 2025.

  • On a quarterly basis, Invested Capital fell 24.64% to $47.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $47.7 million, a 24.64% decrease, with the full-year FY2025 number at $47.7 million, down 24.64% from a year prior.
  • Invested Capital hit $47.7 million in Q4 2025 for Camp4 Therapeutics, down from $58.7 million in the prior quarter.
  • Over the last five years, Invested Capital for CAMP hit a ceiling of $63.3 million in Q4 2024 and a floor of -$159.0 million in Q3 2024.
  • Historically, Invested Capital has averaged -$41.5 million across 3 years, with a median of -$35.7 million in 2023.
  • The widest YoY moves for Invested Capital: up 151.16% in 2024, down 42.51% in 2024.
  • Tracing CAMP's Invested Capital over 3 years: stood at -$123.7 million in 2023, then surged by 151.16% to $63.3 million in 2024, then fell by 24.64% to $47.7 million in 2025.
  • Business Quant data shows Invested Capital for CAMP at $47.7 million in Q4 2025, $58.7 million in Q3 2025, and $40.1 million in Q2 2025.